Упрощенная HTML-версия
353.
Murray C. J. L. Alternative projections of mortality and disability by cause
1990-2020. Global Burden of Disease Study / C. J. L. Мurray, F. D. Lopez //
Lancet. – 1997. – V. 349. – Р. 1498-1504.
354.
Naqvi T. Z. Cerebrovascular mental stress reactivity is impaired in
hypertension / T. Z. Naqvi, H. K. Hyuhn // Cardiovasc. Ultrasound. - № 7. – P.
32.
355.
Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in
obesity and possible role in the development of hypertension / M. Baltatzi [et
al.] // Int. J. Clin. Pract. – 2008. – Vol. 62, № 9. – P. 1432-1440.
356.
Neuropsychiatry and the future of psychiatry and neurology / S. C. Yudofsky
[et al.] // Am. J. Psychiatry. – 2002. – Vol. 159, № 8. – P. 1261-1264.
357.
Norata G. D. Molecular Mechanisms Responsible for the Antiinflammatory
and Protective Effect of HDL on the Endothelium / G. D.Norata, A. L.
Catapano // Vasc. Health. Risk. Manag. – 2005. – Vol. 1, № 2. – P. 119 – 129.
358.
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive
protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol
screening as predictors of peripheral arterial disease / P.M.
et al.] //
359.
Nudear factor-B and arterial Response to ballon injury / B. Cerceka [et al.] //
Atherosclerosis. – 1997. - № 1. – P. 59-66.
360.
Obesity and body fat distribution induce endothelial dysfunction by oxidative
stress. Protective effect of vitamin C / F. Perticone [et al.] // Diabetes. – 2000.
– Vol. 50. – P. 159–165.
361.
Obesity and the risk of heart failure / S. Kenchaiah [et al.] // N. Engl. J. Med. –
2002. – Vol. 347. – P. 305–313.
362.
Obesity and vascular dysfunction / P. A. Stapleton [et al.] // Pathophysiology.
– 2008. – Vol. 15, № 2. – P. 79-89.
363.
Obesity epidemic puts millions at risk from related diseases [press release].
Geneva: World Health Organization. – 1997. – June 12. – No. 46.